Our mission is to improve the life quality of patients depending on painful injectable drugs by offering them the OctoPatch® − a small painless patch that can be easily self-applied to the inner side of the cheek.
Location: Switzerland, Zurich
Employees: 1-10
Investors 2
| Date | Name | Website |
| 10.06.2024 | Venture Ki... | venturekic... |
| 25.03.2024 | VentureLab | venturelab... |
Mentions in press and media 3
| Date | Title | Description |
| 04.09.2025 | Johnson & Johnson acquires Obaris | OBaris AG is a preclinical-stage spin-off from ETH Zurich and the University Hospital Zurich (USZ) founded in 2024. Following six years of research, the startup has developed a technology platform, OctoPatch, a painless suction patch that ... |
| 08.04.2025 | University Hospital Zurich's Health Innovation Hub expands portfolio | The Health Innovation Hub (HIH) is the startup support arm of the Innovation & Startup Center (ISC) of the USZ, which was founded by the USZ in 2018. The aim of the ISC is to promote entrepreneurship and innovation in healthcare at and... |
| 27.03.2024 | Ten startups on a business voyage in Boston | Selected from over 70 applications by a jury of investors and biotech experts, the ten startups selected for the 18th edition of Venture Leaders Biotech will join the roadshow in Boston, one of the world's most important life science hubs.... |